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Background: Group B coxsackieviruses (CVBs) are etio-
logic agents of a number of human diseases that range in
severity from asymptomatic to lethal infections. They are
small, single-stranded RNA icosahedral viruses that
belong to the enterovirus genus of the picornavirus fam-
ily. Structural studies were initiated in light of the infor-
mation available on the cellular receptors for this virus and
to assist in the design of antiviral capsid-binding com-
pounds for the CVBs.
Results: The structure of coxsackievirus B3 (CVB3) has
been solved to a resolution of 3.5 A. The -sandwich
structure of the viral capsid proteins VP1, VP2 and VP3
is conserved between CVB3 and other picornaviruses.
Structural differences between CVB3 and other entero-
viruses and rhinoviruses are located primarily on the
viral surface. The hydrophobic pocket of the VP1
1-sandwich is occupied by a pocket factor, modeled as a
C16 fatty acid. An additional study has shown that the
pocket factor can be displaced by an antiviral com-
pound. Myristate was observed covalently linked to the
N terminus of VP4. Density consistent with the pres-
ence of ions was observed on the icosahedral threefold
and fivefold axes.
Conclusions: The canyon and twofold depression, major
surface depressions, are predicted to be the primary and
secondary receptor-binding sites on CVB3, respectively.
Neutralizing immunogenic sites are predicted to lie on
the extreme surfaces of the capsid at sites that lack amino
acid sequence conservation among the CVBs. The ions
located on the icosahedral threefold and fivefold axes
together with the pocket factor may contribute to the pH
stability of the coxsackieviruses.
Structure 1 5 July 1995, 3:653-667
Key words: coxsackievirus B3, enterovirus, viral myocarditis
Introduction
Picornaviruses are a family of small, non-enveloped,
single-stranded positive-sense RNA viruses. The coding
region of the RNA genome contains a single open read-
ing frame and is translated into one polypeptide. The
structural proteins are cleaved by virally encoded pro-
teinases to yield VPO, VP3 and VP1. Assembly into
mature virion particles is completed by the autocatalytic
cleavage of VP0 into VP4 and VP2. The mature virions
are approximately 300 A in diameter and the interior of
the capsid shell is packed with single-stranded RNA [1].
The virus capsid is composed of 60 protomers, each con-
sisting of one copy of viral proteins VP1-4 arranged in a
T=1 (pseudo T=3) icosahedral lattice [2]. Molecular
weights for picornaviruses, including the RNA, are on
the order of 8 x 106 Da.
In the picornavirus family, the five major genera are the
enteroviruses, rhinoviruses, aphthoviruses, cardioviruses
and hepatoviruses [1]. They are distinguished by physical
properties (pH stability and buoyant density), clinical syn-
dromes [3] and RNA sequence [4]. Atomic resolution
structures are available for four of the five major genera
[5-8]. The enteroviruses are pH stable and survive passage
through the stomach to the lower intestinal tract, where
replication takes place. The enteroviruses of humans are
further classified, on the basis of clinical manifestations,
into polioviruses (3 serotypes), coxsackie A (23 serotypes)
and B (6 serotypes) viruses, echoviruses (34 serotypes)
and human enteroviruses (5 serotypes) [3].
Cell-surface receptors have been isolated and identified
for a number of picornaviruses. Some of the receptors
are members of the immunoglobulin superfamily [9-12],
whereas others belong to different protein classes
[13-16]. The locations of receptor-binding sites for
human rhinovirus (HRV)-16 [17] and HRV14 (N Olson,
P Kolatkar, M Rossmann and T Baker, unpublished data)
have been determined using cryoelectron microscopy
and image reconstruction. These studies showed that
intercellular adhesion molecule-1 (ICAM-1), the recep-
tor for the major group of rhinoviruses, binds into a 15 A
deep canyon surrounding the icosahedral fivefold axes,
and corroborated the canyon hypothesis [18] which was
proposed previously based on the three-dimensional
structure of HRV14 [5], the conservation of amino acid
residues lining the canyon [19,20] and mutational studies
of amino acids located inside the canyon of rhinoviruses
[21] and polioviruses [22].
There is evidence for two CVB receptors on human
HeLa cells: human receptor 1 (HR1) and human recep-
tor 2 (HR2). HR1 is an unidentified 50 kDa protein
which is recognized by all six CVB serotypes and is prob-
ably the major functional receptor for the CVBs [23].
HR2 [24] is a 60-70 kDa protein, recently identified as
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decay-accelerating factor (DAF) or CD55, which is a
complement regulatory protein [25]. DAF is also a recep-
tor for a number of echoviruses [15,16]. The HR2
receptor was identified by isolating variants of CVB3 that
had been adapted to grow on rhabdomyosarcoma (RD)
cells which are normally not susceptible to CVB3 infec-
tion [26]. The ability of these variants to grow on RD
cells was attributed to altered receptor susceptibility of
the virus. HR2, whose function in cell infectivity is not
clear, is probably a minor, low-affinity receptor on HeLa
cells. The identification of at least two CVB receptors
suggests that these viruses may have the ability to recog-
nize and utilize multiple receptors. Alternatively, they
may be part of a receptor complex comprising a number
of different proteins, including HR1 and HR2, that
define the CVB receptor.
Virus-binding competition studies have revealed that
some viruses within the picornavirus family share the
same receptors with other picornaviruses as well as with
unrelated viruses. Coxsackievirus A21 competes directly
with HRV14 for its receptor, ICAM-1, and CVB3 com-
petes for receptor with an unrelated virus, adenovirus 2
(Ad2) [27]. The structure of the receptor-binding
domain of the fiber protein of adenovirus 5 (Ad5), a
virus which is closely related to Ad2, has been solved by
X-ray crystallography [28]. Structural analysis of both
CVB3 and the Ad5 fiber protein would be expected to
reveal similarities in surface topologies and important
features involved in virus-receptor interactions.
Sterling Winthrop Pharmaceuticals Research Division
(SWPRD) and others [29] have synthesized a number of
antiviral agents that are active against rhinoviruses,
polioviruses, coxsackieviruses and other enteroviruses by
inhibiting viral uncoating [30] and sometimes also by
blocking attachment of the virus to the cell [31,32].
Crystallographic studies have shown that these antiviral
compounds bind beneath the canyon floor in a
hydrophobic pocket within the 3-sandwich of VP1
[33-37]. When antiviral compounds bind into the
drug-binding pocket of HRV14 they cause large con-
formational changes, localized to the 13H strand and GH
loop of VP1, deforming the canyon floor and blocking
receptor attachment [31,32]. The native structures of
poliovirus 1-Mahoney (PV1/M), poliovirus 3-Sabin
(PV3/S), HRV1A and HRV16 revealed that the drug-
binding pocket was occupied in its native state by
an unidentified cofactor called the pocket factor
[36,38,39]. The pocket factor is displaced when the
drugs bind and, hence, in the case of HRV1A, HRV16
and polioviruses, the drugs do not cause significant con-
formational change upon binding. It has been suggested
that the pocket factor functions both to stabilize the
virion when in transit between cells, and to destabilize
the capsid after attachment prior to uncoating [36,37].
Although pocket factors have been modeled as fatty
acids, on the basis of the shape of observed electron
density and their hydrophobic environments, they have
not been chemically identified.
Here we present the 3.5 A resolution structure of CVB3
together with an analysis of CVB3 in complex with an
antiviral WIN compound.
Results and discussion
Quality of the electron-density map
Overall, the quality of the electron-density map at 3.5 A
resolution was very good. The main-chain density was
continuous at a density level of 3a above background
(apart from the regions mentioned below). This allowed
the CVB3 amino acid sequence to be built into the elec-
tron-density map without ambiguity. VP1, VP2 and VP3
have the conserved 3-sandwich folding motif observed
for many icosahedral viruses (Fig. 1) [40]. The [3-sand-
wich consists of eight antiparallel 3-strands, B-I, that
form two sheets, BIDG and CHEF
Regions of the amino acid sequence for which there was
no electron density were as follows: in VP1, the N-termi-
nal residues 1001-1012 (amino acid numbering conven-
tion adds 1000, 2000, 3000 and 4000 to the residues of
VP1, VP2, VP3 and VP4, respectively) and residues 1128
and 1130; in VP2, the N-terminal residues 2001-2008;
and in VP4, residues 4012-4024. The two residues
Thr1128 and Gln1130, missing from the electron density
for VP1, are located on the exterior DE loop surrounding
the icosahedral fivefold axis with Co atoms at a viral
radius of 163 A. The lack of density for these residues
results from the electron density averaging procedure,
which used a spherical mask that was slightly too small
(outer radius of 162 A). Residues with weak side-chain
densities include: Glu1026, Lys1054, Lys1085, Lys1259,
Thr1281, Tyr2009, Lys2043, Lys2158, Lys2166, Gln2263,
Arg3035, Lys3041, Glu3060, Arg3073, Ser3078, Lys3144,
Gln4004, Gln4048 and Asn4069. All of these residues are
polar and are located on the exterior or interior surfaces
of the virus capsid where they are exposed to solvent.
Structure of VP1
The N-terminal 12 amino acids of VP1 are absent in the
CVB3 electron density. However, evidence from
poliovirus structures suggests that the N-terminal five
amino acids interact with the N terminus of VP4 at the
fivefold axis [38]. The electron-density map of CVB3
shows very weak density, resembling 3-structure, beneath
residues 4001-4008 of VP4 which may, by analogy to the
polioviruses, be the N terminus of VP1. The interaction
of the N termini of VP1 and VP4 is consistent with the
observation that the N terminus of VP1 is externalized
and becomes exposed to proteases upon the formation of
altered ('A') particles which lack VP4 [41,42].
The DE loop (residues 1125-1137) is the most promi-
nent of the exterior loops found at the fivefold axis. It
runs closest and parallel to the fivefold axis and, as a
result, makes extensive interactions with its icosahedral
fivefold-symmetry-related DE loops. The size and orien-
tation of the CVB3 DE loop presents greater opportu-
nity for these symmetry-related interactions to occur as
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Fig. 1. Stereo C traces for (a) VP1, (b)
VP2, (c) VP3 and (d) VP4 of CVB3 with
every 20th residue labeled.
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compared with the shorter DE loops of PV1/M and
HRV14. Residues in the DE loop are also involved in
interactions with putative ion-binding sites (see below)
along the fivefold axis. Because of the length and exten-
sive protein-protein and protein-ion interactions, the DE
loop may help stabilize virus pentamers and be partially
responsible for the pH stability of CVB3. In addition to
the stabilizing role of the DE loop, Caggana et al. [43]
have identified a single amino acid (Thrl 129) on the DE
loop that is a major determinant of virulence, character-
ized by pancreatitis and hypoglycemia in mice, for
CVB4. Therefore, it appears that the DE loop may play a
role in both virion stability and pathogenicity.
The BC loop (residues 1081-1085) is nine (and five)
amino acids shorter than the BC loop of HRV14 (and
PV1/M) and, as a consequence, it is not as prominent a
surface loop as it is for the polioviruses and rhinoviruses.
This loop flanks the rim of the canyon closest to the
fivefold axes and is an important neutralizing immuno-
genic (NIm) site for the polioviruses and rhinoviruses
[44-47]. CVB4/CVB3 chimera studies have shown that
the BC loop of CVB4 contains a major NIm site [48].
Residues located on the BC loop have been shown to be
responsible for the host-range specificity of poliovirus 2-
Lansing (PV2/L) [49] and, in the case of HRV14 and
HRV16, residues in the BC loop are located within the
ICAM-1 receptor 'footprint' and may play a role in
receptor recognition.
A long, thin, worm-like density feature was found inside
the VP1 3-sandwich at the binding site of antiviral
compounds (discussed below). The height of the elec-
tron density within the pocket was roughly 85-90% of
that of the surrounding protein and somewhat weaker at
the interior end of the pocket, towards the fivefold axis.
This suggested that the pocket in each of the 60 pro-
tomers might be fully occupied with a purely carbon
compound, that the pocket was not fully occupied or
that the moieties in the pocket were not of homo-
geneous length. The unidentified pocket factor, modeled
as a palmitate molecule (16 carbon fatty acid; Fig. 2a), is
very similar in size and shape to that observed in PV1/M
and PV3/S [38]. The polar head group of the pocket
factor is towards the exterior or 'pore' end of the pocket
while the aliphatic chain extends the length of the
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Fig. 2. Averaged electron density maps
showing the VP1 3-sandwich pocket.
(a) CVB3 native electron density and
structure showing the pocket factor in
the middle of the figure, modeled as
palmitate. The map was computed with
I Fnatve I(unit weights) coefficients and
the final phases determined by molecu-
lar replacement electron density averag-
ing. The model is that obtained from
X-PLOR refinement. The structure of the
palmitate molecule, representing the
pocket factor, was obtained by graphi-
cal model building. (b) CVB3 in com-
plex with the antiviral compound WIN
66393 (see Table 1). The view is the
same as shown for (a). The iodine atom
can be seen as a prominent area of den-
sity adjacent to the phenyl ring of the
drug. The map was computed with(I -ki Fnat,,e )(unit weights) coeffi-
cients where k=0.65 was chosen to
equalize the density for the WIN com-
pound and the protein. The superim-
posed structure is as in (a). The WIN
compound structure is based on graphi-
cal model building. Fnative and
Fwin are the structure amplitudes for
the native and drug-soaked crystals.
hydrophobic pocket towards the fivefold axis. For the
two oxygens of the polar head group, the electron den-
sity suggests that one oxygen forms a hydrogen bond
with the side-chain nitrogen of Arg1095 while the sec-
ond oxygen may interact indirectly with the side-chain
oxygen of Ser1184 via a water molecule. The carbon
chain of the fatty acid makes extensive interactions with
the side chains of hydrophobic residues lining the
13-sandwich pocket (Table 1). When comparing the
position of the pocket factors for CVB3, PV1/M,
HRV1A and HRV16, the polar head groups are all in
similar locations at the pore end of the pocket whereas
the aliphatic chains differ significantly in their conforma-
tions and lengths with respect to each other (Fig. 3).
Presumably, this reflects the different shapes of the
pocket interiors for each of the viruses, which are
defined by the amino acids that line the pocket.
Structure of VP2
It has been suggested that the conserved residue Ser2010
is involved in the autocatalytic cleavage of VPO to VP4
and VP2 [50]. However, mutational analysis has shown
that this residue is not essential for the rhinoviruses and
polioviruses [51,52]. For CVB3, a hydrogen bond exists
between Asp2011 and Asn4069, suggesting an autocat-
alytic cleavage mechanism that utilizes an aspartate
residue similar to that proposed for the nodaviruses [53].
The recent structure of PV1/M [54], in which VPO has
not been cleaved, shows that the region near the
C terminus of VP4 and the N terminus of VP2 is very
different in the cleaved and uncleaved structures. Prior to
the maturation cleavage, the environment may be con-
ducive to an aspartate-dependent type of autocatalytic
mechanism, although Basavappa et al. [54] point out that
the scissile bond is close to a conserved histidine residue
(His2195) in the structure of the poliovirus empty capsid.
The largest and most variable surface loop of VP2 is the
'puff' or EF loop (residues 2129-2180). The puff of
CVB3 is six residues shorter than that of PV1/M and
three residues longer than that of HRV14. The CVB3
puff consists of two loops: the first (residues 2129-2154)
lines the rim of the canyon closest to the twofold axes;
the second (residues 2155-2180) sits above the first on
the exterior of the virus surface. This exterior region of
the puff loop contains NIm sites for polioviruses and rhi-
noviruses [44-47]. The puff may play a structural role in
maintaining the shape and amino acid charge characteris-
tics of the canyon and may be directly or indirectly
involved in receptor binding or recognition. In the case
of HRV14, residues within the ICAM-1 footprint
include residues from the puff loop near the the canyon
[17]. In addition, mutational studies of CVB3 have
shown that amino acid changes in the puff loop of VP2,
especially to regions that line the rim of the canyon and
the depression around the twofold axis, often result in
non-viable virus (B Coller, J Muckelbauer, M Rossmann
and S Tracy, unpublished data).
(a)
(b)
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-
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Table 1. CVB3 residues within 4.0 A of WIN 66393, palmitate and the VP4-myristate.
WIN 66393
Distance* CVB3 CVB3
Atom (A) residue atom
Palmitate
Distance* CVB3 CVB3
Atom (A) residue atom
Myristate
Distance* CVB3 CVB3
Atom (A) residue atom
4.1 Tyr1189 C82
3.4 Prol 094 Cy
3.9 Prol 094 Cy
3.0 Met1213 Cy
3.6 Met1213 Cy
3.4 Phel237 CE2
3.6 Metl 213 Cy
3.8 Ilel 092 Cy2
3.7 Phe1237 Ct
3.9 Ilel 092 Cy2
4.2 Phe1237 Cc
3.6 Ile1092 C81
4.1 Leull 6 C81
4.1 Ile1092 C81
3.9 Tyrl 143 CE2
3.5 Tyrl 143 Cy
3.8 Leull116 C81
3.8 Tyrl 143 Cg
3.8 Leulil6 C81
3.5 Leul 116 C81
3.1 Leu1216 C81
3.7 Leul 16 C81
3.7 Leu1216 C81
3.7 Leul 1183 C81
3.8 Tyrl 143 OH
3.9 Leul 116 C82
3.8 Trp1090 C2
3.0 Leu1216 C82
3.3 Tyr1143 C3
3.6 Met1178 CE
3.7 Pro1165 Cy
3.4 Tyrl 1143 C13
3.7 Metl 1178 CE
4.0 Leu1216 C81
3.3 Met1178 CE
3.9 Tyr1143 C13
3.7 Leu1216 C81
2.9 Metl 178 CE
4.0 Prol 165 0
3.1 Metl 178 CE
3.4 Pro1165 Cy
3.7 Tyrl 1143 C1
3.3 Met1178 CE
3.2 Va11167 Cy2
3.4 Serl 166 Ca
3.9 Prol 165 0
01
01
02
C1
C2
C2
C3
C4
C5
C6
C7
C8
C8
C9
C10
ClI
C12
C13
C14
C14
C14
C14
C15
C15
C16
2.6 Argl 095 N2
3.1 ArglO 095 N 11
5.8' Serl 184 Oy
3.7 Argl 095 N,92
3.7 Asn211 N82
3.9 Met1213 Cy
3.8 Prol 094 C8
4.3 Tyrl 189 CE2
4.3 Pro1094 C8
4.4 Phel237 CE2
3.6 Metl 213 Cy
3.9 Iel 092 Cy2
4.0 Leu1114 C81
4.0 IIe1092 Cy2
3.7 IIe1092 C81
4.0 IIe1092 C81
3.0 Leu1116 C81
3.7 Leul116 C81
3.7 Metl 178 CE
3.9 Tyrl 1143 Cp
3.9 Leul1116 C81
3.9 Leu1216 C81
3.1 Metl 178 Ce
3.6 Tyrl 143 C[3
3.0 Metl 178 CE
o11
o11
C1i
C2'
C3'
C4'
C5'
C5'
C5'
C6'
C61
C61
C71
C8'
C8'
C9'
C101
C11'
Cll
C12 1
C13'
C14'
3.2 Thr40282 Oyl
3.5 Ile40301 C81
3.8 Thr40282 Oy1
4.3 Ala40032 C,3
4.8 Ile4030' C81
4.2 Myr2 C5
3.2 Myr s C6
3.8 Myr5 C5
3.8 Myr2 C5
3.2 Myr2 C5
3.6 Myr2 C6
3.6 Myrs C6
4.0 IIe4030' C81
4.2 Myr2 C8
4.2 Myr 5 C8
4.3 Myr2 C8
4.6 Leu30024 C81
4.4 Ile40302 Ci
4.5 Leu30024 C81
3.6 Thr4028 2 0
3.8 Leu30024 C81
4.0 Thr4028 2 0
WIN 66393 C51 C21
II C C 1
N \\ 5NN / C ' C3# t C C* N-C2 °S
-C6 5 N3'=C4'
161 C4
Palmitate
Myristate
o,
C, C3 C5 C7 C9 C,,ll C13 Cl5
02 C2 C4 C, C8 CIO C12 C14 C16
0,
C, C3 C5 C7 C9 C, C13
VP4 C2 C4 C, C8 CIO C12 C14
t Possible water-mediated hydrogen bond. *Distances greater than 4.0 A indicate the nearest residue. §The myristate superscripts
1-5 represent the fivefold-symmetry-related myristates and protein numbering scheme where 1 is the reference structure and 2-5
are arranged looking down the fivefold axis towards the viral center in an anticlockwise manner.
Fig. 3. Pocket factors. C backbone
structure of the CVB3 VP1 -sandwich
is shown in black with the superposi-
tioned structures of the pocket factors:
palmitate (C16) for CVB3 (blue); sphin-
gosine for PV1/M (red); caprate (C10) for
HRV16 (green), and caprylate (C8) for
HRV1A (pink).
C51
N5
C4
C3
C2
N1
C1#
C1#
C2#
C2#
C3#
01*
C1 *
C1 *
C2*
C3*
C4*
C4*
C4*
C5*
C5*
C6*
C6*
C21
C21
161
161
161
Ni'
Ni'
Ni'
C2'
C2'
C2'
N3'
N3'
N3'
C4'
C4'
05'
05'
05'
C41
C41
C41
C41
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Lindberg et al. [55] have identified two amino acid
residues in VP2 that are responsible for the ability of a
CVB3 variant (CVB3-RD) to utilize a second receptor
on the normally unsusceptible RD cells. One of the
residues is Asp2108--Val, which is internal and located
on 3D. The other residue, Thr2151---Ser, is located on
the puff of VP2 and may be involved, directly or indi-
rectly, in receptor recognition. Both valine at 2108 and
serine at 2151 are observed for other isolates of CVB3
(Table 2). The isolate, CVB3/0, which has serine at
position 2151, does not infect RD cells (S Tracy, per-
sonal communication), suggesting that this change alone
is insufficient to permit RD cell binding.
A thin, plate-like feature of electron density was observed
close to residue Trp2038, similar to densities assigned as
RNA for HRV14 [56], polioviruses [38] and HRV16
(A Hadfield, M Oliveira and M Rossmann, unpublished
data). The density can accommodate a purine base and it
appears to make ring-stacking interactions with Trp2038.
No other ordered RNA was observed in the CVB3 elec-
tron-density map.
Structure of VP3
The N-terminal 25 residues of VP3 are located along the
icosahedral fivefold axes at 110 A from the viral center.
The fivefold-symmetry-related N termini form an inter-
twining -barrel cylinder (Fig. 4a) whose structure is
highly conserved in all picornavirus structures deter-
mined so far. This -cylinder structure is likely to be
important in pentamer formation after the release of the
Table 2. Amino acid differences in the capsid proteins of
CVB3 isolates whose sequences have been published.
CVB3
reference
VP1
1023
1045
1080
1092
1180
VP2
2013
2108
2138
2151
VP3
3137
3155
3178
3184
3214
3234
VP4
4016
4030
4051
M* Nancy Nancy
[751 [73]
20 0 Nancy-RD
[76] [77] [551
T T N T T 
S G G G
E K E K E K
L L L L L
V I I I I I
V A A V A A
I V D V V V
N D D D D D
T T T S S S
P P L P P L
V I V V V V
Y F Y F Y Y
Y Y C Y Y Y
V V V V V A
E Q E Q E Q
G R G RG G
I I I I V I
S G G G G G
VP3 termini by post-translational cleavage [5,6]. Resi-
dues 3058-3069 form the knob which is the major sur-
face protrusion of VP3. NIm sites are located on the
knob of rhinoviruses and polioviruses [44-47].
Structure of VP4
Electron density extending from the N terminus of VP4
was identified as myristate, a C 14 fatty acid, covalently
bound to the N-terminal glycine of VP4 (Fig. 4b). Con-
tinuous electron density was observed up to atom C12 of
myristate, but the atoms C13 and C14 were missing in
the map and presumably assume multiple conformations.
The fivefold-related myristates cluster at the interior sur-
face of the virion just below the N-terminal VP3
,3-cylinder (Fig. 4a). The myristate mediates interactions
between the N termini of VP3 and VP4 and is thought
to play an important role in virus assembly by stabilizing
pentamers [57]. It has also been suggested that myristate
may be involved in disassembly by mediating the associa-
tion of virus with cellular membranes [58]. The position
of the myristate is essentially identical to that found in
PV1/M [38]. The carboxylate oxygen of myristate forms
a hydrogen bond with a fivefold-symmetry-related side-
chain oxygen of Thr4028 (Fig. 4b). It has been shown,
by mutagenesis studies, that this interaction is important
for normal viral assembly and infectivity in the polio-
viruses [59]. VP4 meanders from the fivefold axis along
the capsid interior to the threefold axis terminating close
to the N terminus of VP2.
Surface characteristics
The CVB3 canyon surrounding the icosahedral fivefold
axis is not as pronounced as the canyon for the
polioviruses and rhinoviruses. It appears to be bridged at
the narrowest region of the canyon between VP1 and
VP2 (Figs 5,6). The canyon depression of CVB3 (-15 A
deep) is almost coincident with the HRV14 [17] (Fig. 6)
and HRV16 (N Olson, P Kolatkar, M Rossmann and T
Baker, unpublished data) receptor-binding sites. The
extent to which the canyon narrows differs between
CVB3, the rhinoviruses and the polioviruses. The
residues that make up the bridge are predominantly the
C-terminal residues of VP3 along with one or two
residues from the EF loop of VP1. For PV1/M, the last
three residues of VP3 are disordered and, therefore, their
contribution to bridge formation is not observed [6,54].
A second, 15 A deep, surface depression flanks the icosa-
hedral twofold axes (Figs 5,6). Its floor and walls are
lined, predominantly, with residues from VP2 and some
from VP3. Residue 2151, one of the two amino acids
responsible for the RD phenotype of CVB3-RD (dis-
cussed above), projects directly into the twofold depres-
sion (shown in Fig. 6 as a surface residue adjacent to the
twofold depression) and suggests that this surface depres-
sion may serve as a possible receptor-binding site.
Figure 6b shows the conservation of CVB amino acids
on the surface of the CVB3 virion. Sequence alignments
of CVB1, CVB3, CVB4 and CVB5 (A Palmenberg, per-
sonal communication) show that the regions of greatest
*CVB3/M was the strain used in the current structural studies.
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Fig. 4. N terminus of VP4 and myristate.
(a) View of the fivefold-related myris-
tates and N termini of VP4 near the inte-
rior of the virus capsid clustered
beneath the VP3 -cylinder. (b) The
myristate moiety is shown extending
vertically from the terminal glycine of
VP4. Also shown is a section of a sym-
metry-related VP4 (4027'-4030') show-
ing Thr4028', which forms a hydrogen
bond with the carboxylate oxygen of
myristate.
(a) 5-fold axis
Myristat
N terminus of VP4
5-fold axis
7p -cylinder21J:
Myristato
N terminus of VP4
; p 0-cylinder
(b
Fig. 5. The water-accessible surfaces.
Radial depth-cued images viewed down
the icosahedral twofold axis of (a)
CVB3, (b) PV1/M and (c) HRV14.
Regions of dark blue color represent
surface depressions while regions of yel-
low color represent surface protrusions.
(Images courtesy of Jean-Yves Sgro,
Institute for Molecular Virology, Univer-
sity of Wisconsin-Madison and created
using the program GRASP [78].)
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Fig. 6. CVB3 roadmaps. (a) An icosahedral asymmetric unit of CVB3 showing the surface residues relative to the distance from the viral
center. The depth range is from 140.0-165.0 A. The thick black outline represents the 'footprint' of residues for HRV14 that are in con-
tact with its viral receptor. (b) An icosahedral asymmetric unit of CVB3 showing the conservation of residues for the coxsackie B
viruses using CVB1, CVB3, CVB4 and CVB5 sequence alignments (A Palmenberg, personal communication). A score of 4.0 is assigned
for a surface residue where all four CVB sequences match, whereas 1.0 is assigned for no matches.
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sequence conservation coincide with the canyon sur-
rounding the fivefold axis, and the twofold depression.
Amino acids in the canyon of rhinoviruses have been
shown to be the most conserved surface amino acids
[19,20]. The conservation of amino acids for the CVBs
in the canyon and, to a lesser extent, in the twofold
depression supports the hypothesis that the canyon
and/or the twofold depression are receptor-binding sites.
The more extensive conservation of residues in the
canyon as opposed to that in the twofold depression may
distinguish the canyon as the major receptor-binding site
for all six CVB serotypes, whereas the twofold depression
may function as an alternative or second receptor site.
In addition to identifying conserved regions on the sur-
face of the CVBs, regions with no conservation were also
identified (Fig. 6b). These sites, which correspond to
variable loops and C termini on the extreme surface of
the virus, are analogous to NIm sites for the polioviruses
and rhinoviruses and may also contain NIm sites for
CVB3 and other CVBs.
Water molecules and ions
The assignment of water molecules throughout the
structure was not attempted at 3.5 A resolution. How-
ever, regions of the map, namely along the fivefold and
threefold axes and in the drug-binding pocket, showed
peaks of electron density that could reasonably be attrib-
uted to water and were tentatively assigned as such.
Unidentified density, twice the height of the surrounding
protein density, was observed on the icosahedral threefold
Fig. 7. Stereoviews of the electron den-
sity for the putative (a) threefold and (b)
fivefold ions of CVB3 viewed down the
relevant axis towards the viral center. In
(a), the putative Ca2 + appears to be
coordinated by threefold-related aspar-
tic acids (Asp3203) on VP3. In (b), the
ion, at 153 A from the viral center,
appears to make water-mediated inter-
actions with fivefold-related aspartic
acids (Aso1133) on VP1.
axis at the outer surface of the virion, approximately
148 A from the viral center (Fig. 7a). Using EGTA-
soaking experiments, similar density observed for
HRV14 has recently been shown to be Ca2 + coordinated
to Glu3200 (R Zhao and M Rossmann, unpublished
data). Although soaking experiments with EGTA have
not been carried out for CVB3, we propose that the
observed density on the threefold axis is also Ca2+.
Bidentate coordination (-2.5 A distances) occurs with
the six side-chain oxygens of threefold-related aspartic
acids (Asp3203). An additional ligand to a water mol-
ecule occurs directly below the Ca2 +, closer to the viral
center on the threefold axis. Residue 3203 is conserved
among the CVBs as aspartic or glutamic acid, suggesting
that all CVBs may bind Ca2+ at this position. However,
the trend of conservation does not hold for all rhi-
noviruses and enteroviruses and, hence, the threefold
Ca2+ site for the picornaviruses is not ubiquitous.
Two peaks of electron density were observed on the five-
fold axis at 153 A and 147 A from the viral center. These
are also proposed to be ion-binding sites (Fig. 7b). These
peaks, approximately 75% of the height of the surround-
ing protein electron density, appear to make water-medi-
ated interactions with the side-chain oxygen of Asp1133
and with the main-chain oxygen of Glnl 132. Residue
Aspll133 is conserved as aspartic acid for the CVBs and
both Aspll133 and Glnl 132 are located on the DE loop
(discussed above) of VP1. The density of these peaks is
weaker than the threefold ion peak and is poorly defined,
suggesting that the sites on the fivefold axis are not as
well occupied as the putative Ca2 + site on the threefold
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axis. The peak at 153 A corresponds to the putative ion-
binding site previously observed for HRV14, Mengo
virus, HRV1A and HRV16 [5,7,36,39]. The same
EGTA-soaking experiments that identified Ca2 + on the
threefold axis of HRV14 also identified Ca2+ at the five-
fold ion site (R Zhao and M Rossmann, unpublished
data). For HRV14 the level of occupancy of the fivefold
ion site appears to be variable, depending on pH or the
absence or presence of antiviral compounds ([60]; M
Rossmann, unpublished data). The Ca2+ may bind to the
rhinoviruses on account of its presence in the crystalliza-
tion solution or, alternatively, it may bind during the
assembly process. For CVB3, the purification and crystal-
lization solutions do not contain Ca2+ and crystallization
is from NaC1. The favorable protein environment for ion
binding and the analogous ions observed for other picor-
naviruses suggests that CVB3 can bind a cation at the
fivefold site.
Bacteriophage X174 binds Ca2+ on the fivefold and
threefold axes, in addition to a site off the threefold axis
[61,62]. For X174, the binding of Ca2+ initiates the
ejection of DNA through the fivefold vertex in the early
stages of the phage life cycle [63,64]. Kalko et al. [65]
demonstrated how the fivefold axes for some icosahedral
viruses are reminiscent of channel-like ion-binding and
ion-transport proteins. The superposition of the fivefold
axes and ion-binding sites of CVB3 and (bX174 revealed
similar channel-like structures along the fivefold axis
(Fig. 8). The amino acids that line the fivefold channel
for CVB3 are polar, with a high predominance of gluta-
mine, asparagine and glutamic acid residues in the vicin-
ity of the ion-binding site and near the exterior surface
of the capsid. These channels may be involved in impor-
tant early steps of viral disassembly. Indeed, acid-induced
conformational changes of the GH loop of VP1 and the
fivefold 0-cylinder of VP3 plus loss of the Ca 2+ from the
fivefold axis in HRV14 [60] suggest that the fivefold
channels are important in disassembly. However, Flore et
al. [66] propose the occurrence of a different set of con-
formational changes in the formation of poliovirus 'A'
particles in the early stages of uncoating, while intact
pentamers may be intermediates in the disassembly of
aphthoviruses [67] and cardioviruses [68].
The N terminus of VP1 is disordered in CVB3,
polioviruses and rhinoviruses, to a greater or lesser
extent. In many cases, however, sequences in this region
of VP1 display amphipathic helical character [66] show-
ing that the amino acid sequence is prone to helix forma-
tion. This part of the structure is subject to
externalization during the early stages of infection [42].
The variable nature of this structure and its sequence
preference for helicity might suggest that the infection
process requires a major conformational change involving
the amphipathic helix, possibly by a mechanism similar to
the conformational changes observed for influenza virus
hemagglutinin in the process of membrane fusion [69].
Antiviral compound
The antiviral compound, WIN 66393 (synthesized by
SWPRD), was used for CVB3 crystal-soaking studies.
WIN compounds do not inhibit CVB3 attachment to
monkey kidney cells but act by inhibiting viral uncoating
(P Fox, G Diana, F Dutko, J Groarke, D Pevear, unpub-
lished data). WIN 66393 is iodinated on the phenyl ring
(Table 1) and was used as a potential heavy-atom marker
for crystallographic experiments performed in an attempt
to solve positioning, orienting and packing ambiguities
for CVB3 particles described elsewhere [70].
WIN 66393 binds into the hydrophobic 03-sandwich
pocket of VP1 (Fig. 2b). Amino acid residues in the
pocket close to the drug are predominately hydrophobic
(Table 1). The main-chain oxygen of Pro1165 at the inte-
rior end of the pocket and the hydroxyl group of Tryl 143
are the only two polar atoms within 4.0 A of WIN
66393. Conformational changes upon drug binding are
minimal because the pocket is occupied in its native state
by the pocket factor. As WIN 66393 is considerably
shorter than the native pocket factor, the absence of
pocket factor at the ends of the VP1 pocket indicate that
the antiviral compound displaced the pocket factor com-
pletely (compare Fig. 2a,b). There is some indication that
Ile1092 moves (by -1.0 A) to accommodate the substi-
tuted phenyl ring on the WIN compound. In light of the
small conformational changes in the pocket and the over-
lying canyon on the binding of WIN 66393, it is not sur-
prising that receptor attachment is not inhibited
Fig. 8. Fivefold channels. Cat backbone
superposition matching the viral centers
and icosahedral axes of CVB3 (black)
and X174 (gray). The view is perpen-
dicular to the fivefold axis (black verti-
cal line) showing the channel formed
along this axis. The dots on the fivefold
axis show the positions of the ions for
CVB3 (filled dot) and X174 (open dot),
respectively.
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Fig. 9. Structural comparisons of CVB3 with PV1/M, HRV14 and a predicted CVB3 structure [72]. Plots of Ca distances versus CVB3
amino acid sequence for aligned structures of CVB3 with PV1/M, HRV14 and a predicted CVB3 structure are shown for (a) VP1,
(b) VP2, (c) VP3 and (d) VP4. Above plots (a-c) are the Ca structures of regions which show the most differences in structure. The
CVB3 structure is shown in black with PV1/M in red and HRV14 in green. The predicted CVB3 loop structures are not shown. (e) The
deviation (in A) of Ca atoms for PV1/M and HRV14 from equivalent positions in CVB3 VP3 were plotted against the average minimum
base change per codon. The size of the Ca deviation correlates well with the number of nucleic acid base changes. Similar plots were
obtained for VP1 and VP2 (not shown).
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Fig. 10. Sequence alignments of CVB3, PV1/M and HRV14 for (a) VP1, (b) VP2, (c) VP3 and (d) VP4. The numbering shown is for the
CVB3 sequence. Secondary structural elements (for a definition see [5]) are shown above the sequences. Capital letters denote identical
residues for the sequences shown. Underlined residues indicate surface residues for CVB3. Bold-faced type indicates residues that line
the [-sandwich pocket of VP1.
(assuming that the canyon is the receptor-binding site).
Moreover, if the receptor-binding site were elsewhere, the
WIN compound would also fail to inhibit attachment.
WIN compounds with substituted phenyl rings, that
were active against CVB3/M, were found to be inactive
against CVB3-Nancy (P Fox, G Diana, F Dutko,
J Groarke, D Pevear and T Woods, unpublished data).
There are two residues (1092 and 1180) located in the
WIN pocket that differ between CVB3/M and various
isolates of CVB3-Nancy (Table 2). For CVB3-Nancy,
residue 1092 is a leucine instead of an isoleucine and
residue 1180 is an isoleucine instead of a valine.
Moreover, for the rhinoviruses and enteroviruses, residue
1092 is conserved as isoleucine and residue 1180 is
conservatively hydrophobic (valine, leucine or isoleucine).
These two residues are situated across the pocket from
each other with their side chains extending into the
pocket (Fig. 2) and both are near the substituted phenyl
ring of the WIN compound. For CVB3-Nancy, the
change from isoleucine to leucine at 1092, in addition to
Vall180-Ile, may be responsible for the inability of the
virus to bind WIN compounds. By filling the pocket
with bulkier side chains, these residues may block the
binding of drugs in an analogous way to the exclusion
mutants of HRV14 [32]. This is supported by the fact
that WIN compounds with unsubstituted phenyl rings
do not differentiate between CVB3/M and CVB3-
Nancy (G Diana, F Dutko, J Groarke and D Pevear,
unpublished data).
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HRV14 MGAQVStQKsGsHEnqniltngSnqtfTvINYYkDaAStssagQslsmDPSKFTEPvKDlmlKgaPaLN
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Similarity to other picornaviruses
Structural comparisons between the coat proteins of
CVB3 and other picornavirus structures were performed
using methods developed by Rossmann and Argos [71].
Figure 9a-d shows plots of differences in Cot positions
for VP1, VP2, VP3 and VP4 when CVB3 was superim-
posed on PV1/M and HRV14. The degree of amino acid
conservation, expressed as the average minimum base
change, corresponds to the degree of structural similarity
(measured by the root mean square [rms] displacement of
Cot atoms; Fig. 9e). Regions with differences less than 1r
in the deviation of Cot positions correspond to the
p-strands of the conserved P-sandwich. However, many
loops between the -strands displayed differences of up
to 7 A. These are located mostly on the external surfaces
and correspond to regions with the greatest sequence
variability (Fig. 10). Above each plot (Fig. 9a-c) is a Cot
tracing of the regions with greatest structural difference
which represent parts of the virus structure that alter viral
characteristics such as receptor specificity, antigenicity
and stability. Of the three major coat proteins, VP1
shows the most structural diversity and has the lowest
percentage sequence identity of the coat protein subunits
(Table 3), whereas VP3 exhibits the most structural and
sequence similarity. CVB3 shares higher sequence iden-
tity with the polioviruses than with the rhinoviruses
(Table 3). For VP1, HRV14 differs most from CVB3 at
the fivefold loops (BC, DE, FG) whereas PV1/M differs
most from CVB3 at the GH loop lining the canyon
(Fig. 9a). For VP2, while the N and C termini of CVB3
differ slightly from PV1/M and HRV14, the major
regions of difference are the puff (EF loop) and HI loop
(Fig. 9b). For VP3, the major regions of difference are
the knob, the BC loop and the HI loop (Fig. 9c).
Predicted versus crystallographic structure of CVB3
Liljas et al. [72] predicted the three-dimensional structure
of CVB3-Nancy based on the structures of HRV14 and
PV1/M and the amino acid sequence of CVB3-Nancy
[73]. Figure 9a-d includes the predicted structure of
CVB3 where it is compared with the actual X-ray crys-
tallographic structure. The -sheet loops and termini
were the major regions of difference between the pre-
dicted and actual CVB3 structures, which are also the
sites of the major differences described for PV1/M and
HRV14. The predicted structure of CVB3 is about as
different from the actual CVB3 structure as PV1/M is
from CVB3 and, not surprisingly, is least accurate in the
regions of the structure that are most variable and
functionally unique.
Biological implications
The six serotypes of coxsackie B viruses (CVBs)
cause a number of human illnesses that range in
severity from paralysis and death to asymptomatic
infections. CVBs have been recognized as the
major viral agents causing myocarditis in adults
and children. The ability of the CVBs to infect
different tissues and cause disease may be related
to structural changes that take place on the sur-
face of the virus or in the protein capsid shell.
These changes may affect cellular recognition and
may allow the virus to utilize a variety of recep-
tors and, as a consequence, infect a number of
different tissues.
Earlier results have shown that there are at least
two different receptors that CVB3 can use for cell
entry, an observation that may have important
implications for viral pathogenesis. One of the
CVB3 receptors is the same cell-surface molecule
that is used by some adenovirus serotypes. Shape,
amino acid charge, amino acid conservation, CVB
variants and comparison with rhinovirus and
poliovirus structures suggest that the surface
depression around the icosahedral fivefold axes
(the canyon), which is the site of receptor attach-
ment for the rhinoviruses and enteroviruses, and
the depression at the twofold axes are possible sites
of cell attachment.
CVBs, like polioviruses, but in contrast to the rhi-
noviruses, are stable at acid pH. This stability may
be partly attributable to the presence of a large
pocket factor (of cellular origin that binds into the
VP1 -sandwich) and may also be influenced by
the ion-binding sites on the icosahedral threefold
and fivefold axes. Comparisons between CVB3
and other viruses of the ion-binding sites and the
residues lining the icosahedral fivefold channels
suggest that this may be a route for the external-
ization of the N terminus of VP1, VP4 and possi-
bly the nucleic acid genome in the early stages of
viral infection.
Complexes of CVB3 with an antiviral compound
show that such compounds can displace the
pocket factors under conditions used crystallo-
graphically and that there is nearly full occupancy
of the pocket factors in the virus. The presence of
particular amino acid residues lining the pocket
can be correlated with the effective range of the
antiviral agents.
Table 3. Percentage amino acid sequence identities of aligned
capsid proteins for selected enteroviruses and rhinoviruses.*
CVB3 versus CVB3 versus PV1/M versus
PV1/M HRV14 HRV14
VP1 46 37 42
VP2 56 55 54
VP3 56 49 42
VP4 66 60 57
*Amino acid sequences and alignments were obtained from A
Palmenberg (personal communication). Percentage amino
acid identities were calculated as the (number of matches/
average length of the compared pair)x 100 [4].
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Materials and methods
Crystallography
The crystal structure of CVB3 and its complex with an antivi-
ral compound were determined to 3.5 A resolution [70].
CVB3 was purified by a modified procedure of Mapoles et al.
[23] and crystallized at room temperature using 0.75 M NaCl
as precipitant. X-ray diffraction data were collected at the Cor-
nell High Energy Synchrotron Source (CHESS) on the F1 sta-
tion. The CVB3 particles crystallized in a pseudo R32 space
group, although the true space group was P21 (a=574.6 A,
b=302.1 A, c=521.6 A, P=107.7 ° ) with two virions in the
asymmetric unit giving 120-fold non-crystallographic redun-
dancy. The crystals diffracted to 2.7 A resolution and the X-ray
data set was 55% complete to 3.0 A resolution with an
R-merge of 12.8% [70]. Real-space electron-density averaging
and solvent flattening were performed using HRV14 as an ini-
tial phasing model. A structural model was built and partially
refined to 3.5 A resolution. The R-factor for the present
model, not including water molecules, ions, pocket factor or
the N-terminal myristate on VP4, is 26.4%. The rms deviations
in bond distances and bond angles are 0.013 A and 1.8 °,
respectively. Coordinates for CVB3 coat protein have been
deposited in the Brookhaven Protein Data Bank (1COV).
CVB3 amino acid sequence
The strain of CVB3 for which the structure was solved is the
M strain originally characterized by Gauntt et al. [74]. The
amino acid sequence of the capsid protein of CVB3/M was
provided by Dr Steven Tracy, University of Nebraska Medical
Center at Omaha and Dr Charles Gauntt, University of Texas
Health Science Center at San Antonio. Sequence alignments of
the capsid proteins for CVB3/M, HRV14 and PVI/M (Fig.
10) were based on structural superpositions and they agree well
with sequence alignments [4], with some differences in loop
regions. Sequence differences between CVB3/M and other
isolates of CVB3 are listed in Table 2.
Acknowledgements: We gratefully acknowledge Steven Tracy and
Charles Gauntt for the amino acid sequence of the CVB3/M isolate,
Lars Liljas for the predicted CVB3 structure coordinates, Andrea
Hadfield for the HRV16 pocket factor coordinates and Rob
McKenna for the 4X174 coordinates. We would like to thankJean-
Yves Sgro, Institute for Molecular Virology, University of Wiscon-
sin-Madison, for creating beautiful figures as shown in Figure 5 and
Tom Smith for his help creating many of the figures. This work was
funded by grants to MGR from the National Institutes of Health
and Sterling Winthrop Pharmaceuticals Research Division.
References
1. Rueckert, R.R. (1990). Picornaviridae and their replication. In Virol-
ogy. (2nd edn) (Fields, B. & Knipe, D., eds), pp. 507-548, Raven
Press Ltd., New York.
2. Caspar, D.L.D. & Klug, A. (1962). Physical principles in the con-
struction of regular viruses. Cold Spring Harb. Symp. Quant. Biol.
27, 1-24.
3. Melnick, J.L. (1990). Enteroviruses: polioviruses, coxsackieviruses,
echoviruses and newer enteroviruses. In Virology. (2nd edn) (Fields,
B. & Knipe, D., eds), pp. 549-605, Raven Press Ltd., New York.
4. Palmenberg, A.C. (1989). Sequence alignments of picornaviral cap-
sid proteins. In Molecular Aspects of Picornavirus Infection and
Detection. (Semler, B.L. & Ehrenfeld, E., eds), pp. 211-241, Ameri-
can Society for Microbiology, Washington, DC.
5. Rossmann, M.G., et al., & Vriend, G. (1985). Structure of a human
common cold virus and functional relationship to other picor-
naviruses. Nature 317, 145-156.
6. Hogle, J.M., Chow, M. & Filman, D.J. (1985). Three-dimensional
structure of poliovirus at 2.9 A resolution. Science 229, 1358-1365.
7. Luo, M., et al., & Palmenberg, A. (1987). The atomic structure of
Mengo virus at 3.0 A resolution. Science 235, 182-191.
8. Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D. & Brown, F.
(1989). The three-dimensional structure of foot-and-mouth disease
virus at 2.9 A resolution. Nature 337, 709-716.
9. Greve, J.M., et al., & McClelland, A. (1989). The major human rhi-
novirus receptor is ICAM-1. Cell 56, 839-847.
10. Staunton, D.E., Merluzzi, V.J., Rothlein, R., Barton, R., Marlin, S.D.
& Springer, T.A. (1989). A cell adhesion molecule, ICAM-1, is the
major surface receptor for rhinoviruses. Cell 56, 849-853.
11. Huber, S. (1994). VCAM-1 is a receptor for encephalomyocarditis
virus on murine vascular endothelial cells. J. Virol. 68, 3453-3458.
12. Mendelsohn, C.L., Wimmer, E. & Racaniello, V.R. (1989). Cellular
receptor for poliovirus: molecular cloning, nucleotide sequence, and
expression of a new member of the immunoglobulin superfamily.
Cell 56, 855-865.
13. Hofer, F., et al., & Blass, D. (1994). Members of the low density
lipoprotein receptor family mediate cell entry of a minor group com-
mon cold virus. Proc. Natl. Acad. Sci. USA 91, 1839-1842.
14. Bergelson, J.M., Shepley, M.P., Chan, B.M.C., Hemler, M.E. & Fin-
berg, R.W. (1992). Identification of the integrin VLA-2 as a receptor
for echovirus 1. Science 255, 1718-1720.
15. Bergelson, J.M., Chan, M., Solomon, K.R., St. John, N.F., Lin, H. &
Finberg, R.W. (1994). Decay-accelerating factor (CD55), a glycosyl-
phosphatidylinositol-anchored complement regulatory protein, is a
receptor for several echoviruses. Proc. Nat. Acad. Sci. USA 92,
6245-6248.
16. Ward, T., Pipkin, P.A., Clarkson, N.A., Stone, D.M., Minor, P.D. &
Almond, J.W. (1994). Decay-accelerating factor CD55 is identified
as the receptor for echovirus 7 using CELICS, a rapid immuno-focal
cloning method. EMBOJ. 13, 5070-5074.
17. Olson, N.H., et al., & Rossmann, M.G. (1993). Structure of a human
rhinovirus complexed with its receptor molecule. Proc. Natl. Acad.
Sci. USA 90, 507-511.
18. Rossmann, M.G. (1989). The canyon hypothesis. J. Biol. Chem. 264,
14587-14590.
19. Rossmann, M.G. & Palmenberg, A.C. (1988). Conservation of the
putative receptor attachment site in picornaviruses. Virology 164,
373-382.
20. Chapman, M.S. & Rossmann, M.G. (1993). Comparison of surface
properties of picornaviruses: strategies for hiding the receptor site
from immune surveillance. Virology 195, 745-756.
21. Colonno, R.J., Condra, J.H., Mizutani, S., Callahan, P.L., Davies, M.
& Murcko, M.A. (1988). Evidence for the direct involvement of the
rhinovirus canyon in receptor binding. Proc. Natl. Acad. Sci. USA
85, 5449-5453.
22. Colston, E. & Racaniello, V.R. (1994). Soluble receptor-resistant
poliovirus mutants identify surface and internal capsid residues that
control interaction with the cell receptor. EMBOJ. 13, 5855-5862.
23. Mapoles, J.E., Krah, D.L. & Crowell, R.L. (1985). Purification of a
HeLa cell receptor protein for the group B coxsackieviruses. J. Virol.
55, 560-566.
24. Hsu, K.L., Paglini, S., Alstein, B. & Crowell, R.L. (1990). Identifica-
tion of a second cellular receptor for a coxsackievirus B3 variant,
CVB3-RD. In New Aspects of Positive Strand RNA Viruses. (Brinton,
M.A. & Heinz, F.X., eds), pp. 271-277, American Society for Micro-
biology, Washington, DC.
25. Bergelson, J.M., Mohanty, J.G., Crowell, R.L., St. John, N., Lublin,
D.M. & Finberg, R.W. (1995). Coxsackievirus B3 adapted to growth
in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69,
1903-1906.
26. Reagan, K.J., Goldberg, G. & Crowell, R.L. (1984). Altered receptor
specificity of coxsackievirus 83 after growth in rhabdomyosarcoma
cells. J. Virol. 49, 635-640.
27. Lonberg-Holm, K., Crowell, R.L., & Philipson, L. (1976). Unrelated
animal viruses share receptors. Nature 259, 679-681.
28. Xia, D., Henry, L.J., Gerard, R.D. & Deisenhofer, J. (1994). Crystal
structure of the receptor-binding domain of adenovirus type 5 fiber
protein at 1.7 A resolution. Structure 2, 1259-1270.
29. Zhang, A., et al., & Arnold. E. (1993). Structure determination of
antiviral compound SCH 38057 complexed with human rhinovirus
14. J. Mol. Biol. 230, 857-867.
30. Fox, M.P., Otto, M.J. & McKinlay, M.A. (1986). The prevention of
rhinovirus and poliovirus uncoating by WIN 51711: a new antiviral
drug. Antimicrob. Agents Chemother. 30, 110-116.
31. Pevear, D.C., et al., & Dutko, F.J. (1989). Conformational changes in
the floor of the human rhinovirus canyon blocks adsorption to HeLa
cell receptors. J. Virol. 63, 2202-2207.
32. Heinz, B.A., Shepard, D.A & Rueckert, R.R. (1990). Escape mutant
analysis of a drug-binding site can be used to map functions in the
rhinovirus capsid. In Use of X-ray Crystallography in the Design of
Antiviral Agents. (Laver, W.G. & Air, G.M., eds), pp. 173-185, Aca-
demic Press Inc., New York.
Coxsackievirus B3 structure Muckelbauer et al. 667
33. Smith, T.J., et al., & Otto, M.J. (1986). The site of attachment in
human rhinovirus 14 for antiviral agents that inhibit uncoating.
Science 233, 1286-1293.
34. Badger, J., Minor, I., Oliveira, M.A., Smith, T.J. & Rossmann, M.G.
(1989). Structural analysis of antiviral agents that interact with the
capsid of human rhinoviruses. Proteins 6, 1-19.
35. Kim, K.H., et al., & Rossmann, M.G. (1993). A comparison of the
anti-rhinoviral drug binding pocket in HRV14 and HRV1A. J. Mol.
Biol. 230, 206-227.
36. Oliveira, M.A., et al., & Rossmann, M.G. (1993). The structure of
human rhinovirus 16. Structure 1, 51-68.
37. Grant, R.A., Hiremath, C.N., Filman, D.F., Syed, R., Andries, K. &
Hogle, J.M. (1994). Structures of poliovirus complexes with anti-viral
drugs: implications for viral stability and drug design. Curr. Biol. 4,
784-797.
38. Filman, D.J., Syed, R., Chow, M., Macadam, A.J., Minor, P.D. &
Hogle, J. (1989). Structural factors that control conformational transi-
tions and serotype specificity in type 3 poliovirus. EMBO J. 8,
1567-1579.
39. Kim, S., et al., & McKinlay, M.A. (1989). The crystal structure of
human rhinovirus serotype 1 A (HRV1 A). J. Mol. Biol. 210, 91-111.
40. Chelvanayagam, G., Heringa, J. & Argos, P. (1992). Anatomy and
evolution of proteins displaying the viral capsid jellyroll topology.
J. Mol. Biol. 228, 220-242.
41. McGeady, M.L. & Crowell, R.L. (1981). Proteolytic cleavage of VP1
in 'A' particles of coxsackievirus B3 does not appear to mediate
virus uncoating by HeLa cells. J. Gen. Virol. 55, 439-450.
42. Fricks, C.E. & Hogle, J.M. (1990). Cell-induced conformational
change in poliovirus: externalization of the amino terminus of VP1 is
responsible for liposome binding. . Virol. 64, 1934-1945.
43. Caggana, M., Chan, P. & Ramsingh, A. (1993). Identification of a
single amino acid residue in the capsid protein VP1 of coxsackie-
virus B4 that determines the virulent phenotype. J. Virol. 67,
4797-4803.
44. Sherry, B. & Rueckert, R.R. (1985). Evidence for at least two domi-
nant neutralization antigens on human rhinovirus 14. J. Virol. 53,
137-143.
45. Sherry, B., Mosser, A.G., Colonno, R.J. & Rueckert, R.R. (1986). Use
of monoclonal antibodies to identify four neutralization immuno-
gens on a common cold picornavirus, human rhinovirus 14. J. Virol.
57, 246-257.
46. Minor, P.D., Ferguson, M., Evans, D.M., Almond, J.W. & Icenogle,
J.P. (1986). Antigenic structure of polioviruses of serotypes 1, 2 and
3. J. Gen. Virol. 67, 1283-1291.
47. Page, G.S., Mosser, A.G., Hogle, J.M., Filman, D.J., Rueckert, R.R. &
Chow, M. (1988). Three-dimensional structure of poliovirus serotype
1 neutralizing determinants. J. Virol. 63, 1781-1794.
48. Reimann, B.Y., Zell, R. & Kandolf, R. (1991). Mapping of a neutraliz-
ing antigenic site of coxsackievirus B4 by construction of an antigen
chimera. J. Virol. 65, 3475-3480.
49. Murray, M.G., Bradley, J., Yang, X.F., Wimmer, E., Moss, E.G. &
Racaniello, V.R. (1988). Poliovirus host range is determined by a
short amino acid sequence in neutralizing antigenic site 1. Science
241,213-215.
50. Arnold, E., et al., & Wimmer, E. (1987). Implications of the picorna-
virus capsid structure for polyprotein processing. Proc. Natl. Acad.
Sci. USA 84, 21-25.
51. Harber, J.J., Bradley, J., Anderson, C.W. & Wimmer, E. (1991). Catal-
ysis of poliovirus VPO maturation cleavage is not mediated by serine
10 of VP2. J. Virol. 65, 326-334.
52. Lee, W.M., Monroe, S.S. & Rueckert, R.R. (1993). Role of maturation
cleavage in infectivity of picornaviruses: activation of an infecto-
some. J. Virol. 67, 2110-2122.
53. Zlotnick, A., et al., & Johnson, J.E. (1994). Capsid assembly in a fam-
ily of animal viruses primes an autoproteolytic maturation that
depends on a single aspartic acid residue. J. Biol. Chem. 269,
13680-13684.
54. Basavappa, R., Syed, R., Flore, O., Icenogle, J.P., Filman, D.J. &
Hogle, J.M. (1994). Role and mechanism of the maturation cleavage
of VPO in poliovirus assembly: structure of the empty capsid assem-
bly intermediate at 2.9 A resolution. Protein Sci. 3, 1651-1669.
55. Lindberg, M.A., Crowell, R.L., Zell, R., Kandolf, R. & Pettersson, U.
(1992). Mapping of the RD phenotype of the Nancy strain of cox-
sackievirus B3. Virus Res. 24, 187-196.
56. Arnold, E. & Rossmann, M.G. (1990). Analysis of the structure of a
common cold virus, human rhinovirus 14, refined at a resolution of
3.0 A. . Mol. Biol. 211, 763-801.
57. Ansardi, D.C., Porter, D.C. & Morrow, C.D. (1992). Myristylation of
poliovirus capsid precursor P1 is required for assembly of subviral
particles. J. Virol. 66, 4556-4563.
58. Chow, M., Newman, J.F.E., Filman, D., Hogle, J.M., Rowlands, D.J.
& Brown, F. (1987). Myristylation of picornavirus capsid protein VP4
and its structural significance. Nature 327, 482-486.
59. Moscufo, N. & Chow, M. (1992). Myristate-protein interactions in
poliovirus: interactions of VP4 threonine 28 contribute to the struc-
tural conformation of assembly intermediates and the stability of
assembled virions. J. Virol. 66, 6849-6857.
60. Giranda, V.L., et al., & Rueckert, R.R. (1992). Acid-induced struc-
tural changes in human rhinovirus 14: possible role in uncoating.
Proc. Natl. Acad. Sci. USA 89, 10213-10217.
61. McKenna, R., et al., & Incardona, N.L. (1992). Atomic structure of
single-stranded DNA bacteriophage bX174 and its functional impli-
cations. Nature 355, 137-143.
62. Ilag, L.L., McKenna, R., Yadav, M.P., BeMiller, J.N., Incardona, N.L.
& Rossmann, M.G. (1994). Calcium ion-induced structural changes
in bacteriophage ~X1 74. J. Mol. Biol. 244, 291-300.
63. Incardona, N.L. & Selvidge, L. (1973). Mechanism of adsorption and
eclipse of bacteriophage 4X1 74. II. Attachment and eclipse with iso-
lated Escherichia coli cell wall lipopolysaccharide. J. Virol. 11,
775-782.
64. Yazaki, K. (1981). Electron microscopic studies of bacteriophage
4X174 intact and 'eclipsing' particles, and the genome by the stain-
ing and shadowing method. J. Virol Methods 2, 159-167.
65. Kalko, S.G., Cachau, R.E. & Silva, A.M. (1992). Ion channels in
icosahedral virus: a comparative analysis of the structures and bind-
ing sites at their fivefold axes. Biophys. J. 63, 1133-1145.
66. Flore, O., Fricks, C.E., Filman, D.J. & Hogle, J.M. (1990). Conforma-
tional changes in poliovirus assembly and cell entry. Semin. Virol. 1,
429-438.
67. Logan, D., et al., & Fry, E. (1993). Structure of a major immunogenic
site on foot-and-mouth disease virus. Nature 362, 566-568.
68. Hall, L. & Rueckert, R.R. (1971). Infection of mouse fibroblasts by
cardioviruses: premature uncoating and its prevention by elevated
pH and magnesium chloride. Virology 43, 152-165.
69. Bullough, P.A., Hughson, F.M., Skehel, J.J. & Wiley, D.C. (1994).
Structure of influenza haemagglutinin at the pH of membrane
fusion. Nature 371, 37-43.
70. Muckelbauer, J.K., et al., & Rossmann, M.G. (1995). The structure
determination of coxsackievirus B3 to 3.5 A resolution. Acta Crystal-
logr. D., in press.
71. Rossmann, M.G. & Argos. P. (1976). Exploring structural homology
of proteins. J. Mol. Biol. 105, 75-95.
72. Liljas, L., Lindberg, M.A. & Pettersson, U. (1993). Modelling of the
tertiary structure of CVB3 from the structure of poliovirus and rhi-
novirus. Scand. J. Infect. Dis. Suppl. 89, 15-24.
73. Lindberg, M.A., Stlhandske, P.O.K. & Pettersson, U. (1987).
Genome of coxsackievirus B3. Virology 156, 50-63.
74. Gauntt, C.J., Trousdale, M.D., LaBadie, D.R.L., Paque, R.E. &
Nealon, T. (1979). Properties of coxsackievirus B3 variants which
are amyocarditic or myocarditic for mice. J. Med. Virol. 3, 207-220.
75. Klump, W.M., Bergmann, I., Muller, B.C., Ameis, D. & Kandolf, R.
(1990). Complete nucleotide sequence of infectious coxsackievirus
B3 cDNA: two initial 5' uridine residues are regained during plus-
strand RNA syntheses. J. Virol. 64, 1573-1583.
76. Tracy, S., Chapman, N.M. & Tu, Z. (1992). Coxsackievirus B3 from
an infectious cDNA is cardiovirulent in mice. Arch. Virol. 122,
398-409.
77. Chapman, N.M., Tu, Z., Tracy, S. & Gauntt, C.J. (1994). An infec-
tious cDNA copy of the genome of a non-cardiovirulent coxsackie-
virus B3 strain: its complete sequence analysis and comparison to
the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135,
115-130.
78. Nicholls, A., Sharp, K. & Honig, B. (1991). Protein folding and asso-
ciation: insights from the interfacial and thermodynamic properties
of hydrocarbons. Proteins 11, 281-296.
Received: 28 Mar 1995; revisions requested: 21 Apr 1995;
revisions received: 4 May 1995. Accepted: 4 May 1995.
